(Q74138408)
Statements
Pharmacological effects of SB 220025, a selective inhibitor of P38 mitogen-activated protein kinase, in angiogenesis and chronic inflammatory disease models (English)
Jackson JR
Bolognese B
Hillegass L
Kassis S
Adams J
Griswold DE
1 February 1998